Clinical Trials Browser

Phase 3 × capivasertib × Clear all

Locally Advanced (Inoperable) or Metastatic Breast Cancer

NCT06982521 2026-05-08

ReDiscover-2

Phase 3 Recruiting

540 enrolled

Breast

Breast Neoplasms

NCT04493853 2026-05-05

CAPItello-281

Phase 3 Active not recruiting

1,012 enrolled

Genitourinary

Prostatic Neoplasms

NCT04305496 2026-04-30

CAPItello-291

Phase 3 Active not recruiting

818 enrolled 19 charts 1 FDA

Breast

Locally Advanced (Inoperable) or Metastatic Breast Cancer

NCT06764186 2026-04-08

CAPItana

Phase 3 Active not recruiting

101 enrolled

Breast

Breast Neoplasms

NCT06635447 2026-03-27

CAPItrue

Phase 3 Active not recruiting

258 enrolled

Breast

Breast Neoplasms, Disease Progression

NCT07281833 2026-02-27

CAPIcorn

Phase 3 Recruiting

250 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis, Disease Progression

NCT03997123 2025-12-22

CAPItello-290

Phase 3 Active not recruiting

923 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03903835 2025-04-09

ProBio

Phase 3 Recruiting

750 enrolled

Genitourinary

Metastatic Castration-resistant Prostate Cancer (mCRPC)

NCT05348577 2025-01-27

CAPItello280

Phase 3 Active not recruiting

1,035 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Clinical Trials

CAPItello-292

ReDiscover-2

CAPItello-281

CAPItello-291

CAPItana

CAPItrue

CAPIcorn

CAPItello-290

ProBio

CAPItello280